Our Department

Department Alumni Fest 2016

Subscribe to email list

Please select the email list(s) to which you wish to subscribe.

User menu

Publications by Paul Gustafson


Gustafson P, McCandless LC. When Is a Sensitivity Parameter Exactly That?. Statistical Science. Institute of Mathematical Statistics; 2018;33:86–95.
Campbell H, Gustafson P. Conditional equivalence testing: An alternative remedy for publication bias. PloS one. Public Library of Science; 2018;13:e0195145.
Xia M, Gustafson P. Bayesian inference for unidirectional misclassification of a binary response trait. Statistics in medicine. Wiley Online Library; 2018;37:933–947.
Shupler M, Godwin W, Frostad J, Gustafson P, Arku RE, Brauer M. Global estimation of exposure to fine particulate matter (PM2. 5) from household air pollution. Environment international. Elsevier; 2018;120:354–363.
Karim MEhsanul, Petkau J, Gustafson P, Platt RW, Tremlett H, Group BAMSStudy. Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies. Statistical methods in medical research. SAGE Publications Sage UK: London, England; 2018;27:1709–1722.


Högg T, Petkau J, Zhao Y, Gustafson P, Wijnands JMA, Tremlett H. Bayesian analysis of pair-matched case-control studies subject to outcome misclassification. Statistics in medicine. Wiley Online Library; 2017;36:4196–4213.
Béliveau A, Goring S, Platt RW, Gustafson P. Network meta-analysis of disconnected networks: How dangerous are random baseline treatment effects?. Research synthesis methods. Wiley Online Library; 2017;8:465–474.
McCandless LC, Gustafson P. A comparison of Bayesian and Monte Carlo sensitivity analysis for unmeasured confounding. Statistics in medicine. Wiley Online Library; 2017;36:2887–2901.
Karim MEhsanul, Petkau J, Gustafson P, Tremlett H, Group TBeams Stud. On the application of statistical learning approaches to construct inverse probability weights in marginal structural cox models: hedging against weight-model misspecification. Communications in Statistics-Simulation and Computation. Taylor & Francis; 2017;46:7668–7697.
Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Buxton JA, et al. Incidence, risk factors, and prevention of hepatitis C reinfection: a population-based cohort study. The Lancet Gastroenterology & Hepatology. Elsevier; 2017;2:200–210.
Islam N, Krajden M, Gilbert M, Gustafson P, Yu A, Kuo M, et al. Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers Cohort. Journal of viral hepatitis. Wiley Online Library; 2017;24:421–429.
Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Wong J, et al. Hepatitis C cross-genotype immunity and implications for vaccine development. Scientific reports. Nature Publishing Group; 2017;7:12326.
Burstyn I, Gustafson P, Pintos J, Lavoué J, Siemiatycki J. Correction of odds ratios in case-control studies for exposure misclassification with partial knowledge of the degree of agreement among experts who assessed exposures. Occup Environ Med. BMJ Publishing Group Ltd; 2017;:oemed–2017.


Falasinnu T, Gilbert M, Gustafson P, Shoveller J. A validation study of a clinical prediction rule for screening asymptomatic chlamydia and gonorrhoea infections among heterosexuals in British Columbia. Sexually transmitted infections. BMJ Publishing Group Ltd; 2016;92:12–18.
Falasinnu T, Gilbert M, Gustafson P, Shoveller J. An assessment of population-based screening guidelines versus clinical prediction rules for chlamydia and gonorrhea case finding. Preventive medicine. Academic Press; 2016;89:51–56.
Goring SM, Gustafson P, Liu Y, Saab S, Cline SK, Platt RW. Disconnected by design: analytic approach in treatment networks having no common comparator. Research synthesis methods. Wiley Online Library; 2016;.
Karim MEhsanul, Gustafson P, Petkau J, Tremlett H. Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies. American Journal of Epidemiology. Oxford University Press; 2016;:kwv445.
Xia M, Gustafson P. Bayesian regression models adjusting for unidirectional covariate misclassification. Canadian Journal of Statistics. 2016;44:198–218.
Zhang T, Kingwell E, De Jong HJI, Zhu F, Zhao Y, Carruthers R, et al. Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression. Pharmacoepidemiology and Drug Safety. 2016;.


Zhang T, Shirani A, Zhao Y, Karim ME, Gustafson P, Petkau J, et al. Beta-interferon exposure and onset of secondary progressive multiple sclerosis. European Journal of Neurology. Wiley Online Library; 2015;22:990–1000.
Etminan M, Luo H, Gustafson P. Risk of intracranial hypertension with intrauterine levonorgestrel. Therapeutic advances in drug safety. SAGE Publications; 2015;6:110–113.
Shirani A, Zhao Y, Petkau J, Gustafson P, Karim MEhsanul, Evans C, et al. Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment. BioMed research international. Hindawi Publishing Corporation; 2015;2015.
Gustafson P. Discussion of ``On Bayesian Estimation of Marginal Structural Models''. Biometrics. Wiley-Blackwell; 2015;71:291–293.


Gustafson P. Bayesian Statistical Methodology for Observational Health Sciences Data. Statistics in Action: A Canadian Outlook. CRC Press; 2014;:163.
Gustafson P, Greenland S. Misclassification. In Handbook of Epidemiology. Springer; 2014. pp. 639–658.
Shirani A, Zhao Y, Karim ME, Petkau J, Gustafson P, Evans C, et al. Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study. European Journal of Neurology. Wiley Online Library; 2014;21:835–844.
Evans C, Zhu F, Kingwell E, Shirani A, Kop ML, Petkau J, et al. Association between beta-interferon exposure and hospital events in multiple sclerosis. Pharmacoepidemiology and drug safety. Wiley Online Library; 2014;23:1213–1222.
Sighoko D, Liu J, Hou N, Gustafson P, Huo D. Discordance in hormone receptor status among primary, metastatic, and second primary breast cancers: biological difference or misclassification?. The oncologist. AlphaMed Press; 2014;19:592–601.
Falasinnu T, Gilbert M, Gustafson P, Shoveller J. Deriving and validating a risk estimation tool for screening asymptomatic chlamydia and gonorrhea. Sexually transmitted diseases. LWW; 2014;41:706–712.
Falasinnu T, Gilbert M, Salway THottes, Gustafson P, Ogilvie G, Shoveller J. Predictors identifying those at increased risk for STDs: a theory-guided review of empirical literature and clinical guidelines. International journal of STD & AIDS. SAGE Publications; 2014;:0956462414555930.
Falasinnu T, Gustafson P, Hottes TSalway, Gilbert M, Ogilvie G, Shoveller J. A critical appraisal of risk models for predicting sexually transmitted infections. Sexually transmitted diseases. LWW; 2014;41:321–330.
Wang D, Gustafson P. On the Impact of Misclassification in an Ordinal Exposure Variable. Epidemiologic Methods. 2014;3:97–106.
Karim MEhsanul, Gustafson P, Petkau J, Zhao Y, Shirani A, Kingwell E, et al. Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort. American journal of epidemiology. Oxford University Press; 2014;180:160–171.
Xia M, Gustafson P. Bayesian sensitivity analyses for hidden sub-populations in weighted sampling. Canadian Journal of Statistics. Wiley Online Library; 2014;42:436–450.
Gustafson P, McCandless L. Commentary: Priors, Parameters, and Probability: A Bayesian Perspective on Sensitivity Analysis. Epidemiology. LWW; 2014;25:910–912.


Gustafson P, Gilbert M, Xia M, Michelow W, Robert W, Trussler T, et al. Impact of Statistical Adjustment for Frequency of Venue Attendance in a Venue-based Survey of Men Who Have Sex With Men. American Journal of Epidemiology. Oxford University Press; 2013;177:1157–1164.
Gustafson P. Bayesian Analysis of Frailty Models. Handbook of Survival Analysis. CRC Press; 2013;:475.
Shirani A, Zhao Y, Karim MEhsanul, Evans C, Kingwell E, van der Kop ML, et al. Interferon beta and long-term disability in multiple sclerosis. JAMA neurology. American Medical Association; 2013;70:651–653.
Luo H, Burstyn I, Gustafson P. Investigations of Gene-Disease Associations: Costs and Benefits of Environmental Data. Epidemiology. LWW; 2013;24:562–568.
Falasinnu T, Gustafson P, Gilbert M, Shoveller J. Risk prediction in sexual health contexts: Protocol. JMIR research protocols. JMIR Publications Inc.; 2013;2.
Burstyn I, de Vocht F, Gustafson P. What do measures of agreement ($ąppa$) tell us about quality of exposure assessment? Theoretical analysis and numerical simulation. BMJ open. British Medical Journal Publishing Group; 2013;3:e003952.
Xing L, Burstyn I, Richardson DB, Gustafson P. A comparison of Bayesian hierarchical modeling with group-based exposure assessment in occupational epidemiology. Statistics in medicine [Internet]. Wiley Online Library; 2013;. http://onlinelibrary.wiley.com/doi/10.1002/sim.5791/abstract


Shirani A, Zhao Y, Karim ME, Evans C, Kingwell E, van der Kop ML, et al. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA: The Journal of the American Medical Association [Internet]. American Medical Association; 2012;308:247–256. http://jama.jamanetwork.com/article.aspx?articleid=1217239